Although the mechanisms responsible for the varying effects of TRPV-1 agonists on cardiomyocytes remain unclear, a recent report suggested that OLDA attenuates ischemia/reperfusion injury of hearts via TRPV-1 activation25. Here, TRPV1 is linked to ischemia.